In Ireland, a nation with approximately 300,000 people living with diabetes, the incidence of amputations among diabetic patients has reached a concerning level. Reports indicate that 671 patients underwent amputations due to diabetic foot ulcers (DFUs ) last year, which not only results in life-altering consequences for individuals but also poses a significant economic burden on the healthcare system. These statistics emphasize the importance of implementing this evidence-based treatment to tackle this growing crisis.
DFUs are primarily caused by poor circulation and reduced oxygen supply to the affected area, impairing the body's ability to heal. Hyperbaric oxygenation addresses this issue by saturating the bloodstream with increased levels of oxygen. This surplus oxygen reaches the damaged tissues, stimulating cell growth, reducing inflammation, fighting infection, and promoting faster wound healing. Additionally, HBOT enhances the formation of new blood vessels, boosting circulation and oxygenation in the affected area, ultimately saving limbs from amputation.
Countless success stories from individuals who have benefited from HBOT underline its potential to transform lives and restore hope for those living with DFUs. A 2018 study showed a 74.2 per cent successful healing rate of diabetic foot ulcers in 682 patients.
Given the rising amputation rates and the large diabetic population in Ireland, it is imperative to introduce and expand the availability of hyperbaric oxygenation. By integrating HBOT into the standard treatment protocol for DFUs, healthcare providers can effectively combat the complications associated with diabetic foot ulcers, reduce the burden on patients, families, and the healthcare system, and ultimately save limbs and lives.
Contact OxyGeneration on 091 394444 to find out more.
